Page 5 - Target Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Target segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Target Segment Today - Breaking & Trending Today

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector
Posted On:
2021-03-06 04:25:29
(Time Zone: Arizona, USA)
Aarti Speciality Chemicals Limited (ASCL), a wholly-owned subsidiary of Aarti Drugs Limited (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-relian ....

United States , Adhish Patil , Atmanirbhar Bharat , Government Of India Department Pharmaceuticals , Aarti Drugs Limited , Aarti Speciality Chemicals , Aarti Speciality Chemicals Limited , Ministry Of Chemicals , Aarti Drugs , Speciality Chemicals Limited , Time Zone , Production Linked Incentive , Chemical Synthesis , Key Starting Materials , Drug Intermediates , Active Pharmaceutical Ingredients , Target Segments , Target Segment , Key Chemical Synthesis Based , Chief Financial Officer , Drugs Limited , Balance Sheet , Mutual Funds , New Issue , Public Issue , Rights Issue ,

Atmanirbhar Pharma Sector: Govt Clears 19 Applications With Committed Investment Of Rs 4,623 Crore Under PLI Scheme

Atmanirbhar Pharma Sector: Govt Clears 19 Applications With Committed Investment Of Rs 4,623 Crore Under PLI Scheme
Prime Minister Narendra Modi with Finance Minister Nirmala Sitharaman.
With an objective to attain self-reliance and reduce import dependence in India s pharmaceutical sector, the government has cleared 19 applications with a committed investment of Rs 4,623.01 crore under its ambitious production linked incentive (PLI) scheme for the promotion of domestic manufacturing of critical key drug intermediates and active pharmaceutical ingredients (APIs), reports
Economic Times.
The development comes as the Department of Pharmaceuticals had launched a PLI Scheme for promotion of their domestic manufacturing by setting up greenfield plants with minimum domestic value addition in four different Target Segments two in fermentation based with at least 90 per cent and two in Chemical Synthesis based with at least 70 per cent - with a total outlay of Rs. 6,940 ....

Natural Biogenex Pvt Ltd , Symbiotec Pharmalab Pvt Ltd , Aartispeciality Chemicals Ltd , Hindys Lab Pvt Ltd , Optimus Drugs Pvt Ltd , Department Of Pharmaceuticals , Macleods Pharmaceutical Ltd , Sudarshanpharma Industries Ltd , Sadhana Nitro Chem Ltd , Saraca Laboratories Ltd , Emmennarpharma Pvt Ltd , Chemical Synthesis , Optimus Drugs Pvt , Sadhana Nitro Chem , Target Segment , Active Pharmaceutical Ingredient Api , Aatmanirbhar Bharat , Pharmaceutical Sector , Key Drugs , உகந்த மருந்துகள் பிரைவேட் லிமிடெட் , துறை ஆஃப் மருந்துகள் , மக்லாட்ஸ் மருந்து லிமிடெட் , சாதனா நைட்ரோ செம் லிமிடெட் , இரசாயன தொகுப்பு , உகந்த மருந்துகள் பிரைவேட் , சாதனா நைட்ரோ செம் ,